PortfoliosLab logoPortfoliosLab logo
XLV vs. PBPH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XLV vs. PBPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in State Street Health Care Select Sector SPDR ETF (XLV) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XLV achieves a -4.29% return, which is significantly lower than PBPH's -1.13% return.


XLV

1D
0.79%
1M
1.95%
YTD
-4.29%
6M
-4.06%
1Y
12.89%
3Y*
5.98%
5Y*
5.55%
10Y*
9.20%

PBPH

1D
0.58%
1M
0.07%
YTD
-1.13%
6M
-0.02%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

XLV vs. PBPH - Yearly Performance Comparison


Correlation

The correlation between XLV and PBPH is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (All Time)
Calculated using the full available price history since Nov 26, 2025

0.86

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XLV vs. PBPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XLV
XLV Risk / Return Rank: 2424
Overall Rank
XLV Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
XLV Sortino Ratio Rank: 2626
Sortino Ratio Rank
XLV Omega Ratio Rank: 2323
Omega Ratio Rank
XLV Calmar Ratio Rank: 2626
Calmar Ratio Rank
XLV Martin Ratio Rank: 2323
Martin Ratio Rank

PBPH
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XLV vs. PBPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR ETF (XLV) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XLVPBPHDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.16

Calmar ratioReturn relative to maximum drawdown

1.24

Martin ratioReturn relative to average drawdown

2.99

XLV vs. PBPH - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


XLVPBPHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.88

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.38

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.56

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

-0.04

+0.50

Drawdowns

XLV vs. PBPH - Drawdown Comparison

The maximum XLV drawdown since its inception was -39.17%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for XLV and PBPH.


Loading charts...

Drawdown Indicators


XLVPBPHDifference

Max Drawdown

Largest peak-to-trough decline

-39.17%

-11.10%

-28.07%

Max Drawdown (1Y)

Largest decline over 1 year

-10.47%

Max Drawdown (3Y)

Largest decline over 3 years

-17.11%

Max Drawdown (5Y)

Largest decline over 5 years

-17.11%

Max Drawdown (10Y)

Largest decline over 10 years

-28.40%

Current Drawdown

Current decline from peak

-7.52%

-8.69%

+1.17%

Average Drawdown

Average peak-to-trough decline

-7.12%

-4.23%

-2.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.32%

Volatility

XLV vs. PBPH - Volatility Comparison


Loading charts...

Volatility by Period


XLVPBPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.10%

Volatility (6M)

Calculated over the trailing 6-month period

10.24%

Volatility (1Y)

Calculated over the trailing 1-year period

14.67%

16.78%

-2.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.69%

16.78%

-2.09%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.55%

16.78%

-0.23%

XLV vs. PBPH - Expense Ratio Comparison

XLV has a 0.08% expense ratio, which is lower than PBPH's 0.13% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.


Dividends

XLV vs. PBPH - Dividend Comparison

XLV's dividend yield for the trailing twelve months is around 1.70%, more than PBPH's 0.09% yield.


PositionTTM20252024202320222021202020192018201720162015
PBPH
Portfolio Building Block World Pharma and Biotech Index ETF
0.09%0.09%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XLV
State Street Health Care Select Sector SPDR ETF
1.70%1.60%1.67%1.59%1.47%1.33%1.49%2.17%1.57%1.47%1.60%1.43%

Frequently Asked Questions


XLV and PBPH have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XLV is cheaper at 0.08% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLV is cheaper with a 0.08% expense ratio, compared with 0.13% for PBPH.

XLV has the higher dividend yield at 1.70%, compared with 0.09% for PBPH.

XLV tracks Health Care Select Sector Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: State Street and Portfolio Building Block. Their fees differ too: 0.08% for XLV and 0.13% for PBPH.

Portfolio Optimizer

Find the right allocation for XLV and PBPH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer